• About
    • Management
    • Our Culture
    • Social Responsibility
    • Pharmaron Learning
  • Services
    • Laboratory Chemistry
    • Biosciences
    • Chemistry Manufacturing And Control
    • Safety Assessment
    • Radiolabelled Sciences
    • Clinical Development
    • Integrated Drug Discovery Collaborations
  • Locations
  • News & Publications
    • News
    • Pharmaron-5
    • Symposium And Forums
    • Publications
  • Investors
  • Careers
  • Contact
EN 简 繁

Investor Relations

 

  • Home
  • Investors
  • H Share
  • Corporate Governance
  • Corporate Information
  • Corporate Governance
  • Information Disclosure
    • Announcements & Circulars
    • Prospectus
    • Financial Reports
  • Corporate Presentations
  • Stock Quote
  • Investor Relations Contacts
Corporate Governance
  • UK Modern Slavery Act Statement for the Year 2023
  • Tax Policy
  • Code of Conduct for Business Partners
  • Code of Conduct
  • Articles of Association
  • Terms of Reference of the Audit Committee of the Board
  • Terms of Reference of the Nomination Committee of the Board
  • Terms of Reference of the Remuneration and Appraisal Committee of the Board
  • List of Directors and their Roles and Functions
  • Board Diversity Policy
  • Shareholders' Communication Policy
  • Procedure for a Shareholder to Nominate a Person for Election as a Director

Serve Our Partners to Succeed

  • © 2019 Pharmaron
  • Contact Us
  • Developed by Euroland IR
  • Follow us via
  •